Latest Insider Transactions at Willis Towers Watson PLC (WTW)
This section provides a real-time view of insider transactions for Willis Towers Watson PLC (WTW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WILLIS TOWERS WATSON PLC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WILLIS TOWERS WATSON PLC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2022
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,359
-4.23%
|
$467,082
$198.47 P/Share
|
|
Jul 20
2022
|
Carl Aaron Hess Chief Executive Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
34
+0.06%
|
-
|
|
Jul 20
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
1,483
-1.55%
|
$293,634
$198.47 P/Share
|
|
Jul 20
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
34
+0.04%
|
-
|
|
Jul 20
2022
|
Adam Garrard Head of Risk & Broking |
SELL
Payment of exercise price or tax liability
|
Direct |
1,592
-11.33%
|
$315,216
$198.47 P/Share
|
|
Jul 20
2022
|
Adam Garrard Head of Risk & Broking |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
25
+0.18%
|
-
|
|
Jul 20
2022
|
Matthew Furman General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,866
-6.97%
|
$369,468
$198.47 P/Share
|
|
Jul 20
2022
|
Matthew Furman General Counsel |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
26
+0.1%
|
-
|
|
Jul 20
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
713
-4.62%
|
$141,174
$198.47 P/Share
|
|
Jul 20
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
22
+0.14%
|
-
|
|
Jun 08
2022
|
Michael P. Hammond Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+46.47%
|
-
|
|
Jun 08
2022
|
Michael P. Hammond Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-48.06%
|
$28,424
$209.84 P/Share
|
|
Jun 08
2022
|
Victor F Ganzi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.6%
|
$26,752
$209.84 P/Share
|
|
Jun 08
2022
|
Fumbi F. Chima Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,574
+49.1%
|
-
|
|
Jun 08
2022
|
Fumbi F. Chima Director |
SELL
Payment of exercise price or tax liability
|
Direct |
54
-48.21%
|
$11,286
$209.84 P/Share
|
|
Jun 08
2022
|
Brendan R Oneill Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+6.46%
|
-
|
|
Jun 08
2022
|
Michelle R Swanback Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+46.47%
|
-
|
|
Jun 08
2022
|
Michelle R Swanback Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-48.06%
|
$28,424
$209.84 P/Share
|
|
Jun 08
2022
|
Linda D Rabbitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,574
+9.19%
|
-
|
|
Jun 08
2022
|
Paul D Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,453
+10.48%
|
-
|
|
Jun 08
2022
|
Inga K Beale Director |
BUY
Grant, award, or other acquisition
|
Direct |
968
+46.47%
|
-
|
|
Jun 08
2022
|
Inga K Beale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
136
-48.06%
|
$28,424
$209.84 P/Share
|
|
Jun 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.45%
|
$294,000
$210.67 P/Share
|
|
May 26
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Bona fide gift
|
Indirect |
1,205
+15.3%
|
-
|
|
May 26
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Bona fide gift
|
Direct |
1,205
-1.61%
|
-
|
|
May 11
2022
|
Anna C Catalano Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-4.64%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Wendy E Lane Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-3.67%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Linda D Rabbitt Director |
SELL
Payment of exercise price or tax liability
|
Direct |
518
-3.57%
|
$106,708
$206.35 P/Share
|
|
May 11
2022
|
Paul D Thomas Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-2.59%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Victor F Ganzi Director |
SELL
Payment of exercise price or tax liability
|
Direct |
791
-3.55%
|
$162,946
$206.35 P/Share
|
|
May 11
2022
|
Wilhelm Zeller Director |
BUY
Grant, award, or other acquisition
|
Direct |
291
+3.01%
|
$59,946
$206.35 P/Share
|
|
May 11
2022
|
Brendan R Oneill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-2.18%
|
$59,946
$206.35 P/Share
|
|
May 02
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,000
-3.38%
|
$428,000
$214.1 P/Share
|
|
May 02
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-0.71%
|
$299,600
$214.34 P/Share
|
|
Apr 01
2022
|
Fumbi F. Chima Director |
BUY
Grant, award, or other acquisition
|
Direct |
112
+50.0%
|
-
|
|
Apr 01
2022
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
694
+21.21%
|
-
|
|
Apr 01
2022
|
Kristy D Banas Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
480
-20.3%
|
$108,960
$227.62 P/Share
|
|
Apr 01
2022
|
Kristy D Banas Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
480
+16.87%
|
-
|
|
Apr 01
2022
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
1,013
+34.92%
|
-
|
|
Apr 01
2022
|
Imran Ahmed Qureshi Head of North America |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,014
-53.68%
|
$230,178
$227.62 P/Share
|
|
Apr 01
2022
|
Imran Ahmed Qureshi Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
1,014
+34.93%
|
-
|
|
Apr 01
2022
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
1,026
+1.35%
|
-
|
|
Apr 01
2022
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
1,151
+7.33%
|
-
|
|
Apr 01
2022
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
105
+20.15%
|
-
|
|
Apr 01
2022
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,684
+9.86%
|
-
|
|
Apr 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
1,197
+1.2%
|
-
|
|
Apr 01
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
1,400
-1.42%
|
$330,400
$236.88 P/Share
|
|
Apr 01
2022
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
1,197
+7.86%
|
-
|
|
Apr 01
2022
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
931
+3.37%
|
-
|
|
Apr 01
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,013
+6.17%
|
-
|